Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Bladder cancer | R-HSA-9700206 | map05219 | AG-028671 | None | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | AG-028671 | None | drug-path |
| Basal transcription factors | R-HSA-3232118 | map03022 | AG-028671 | None | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | 6-bromoindirubin-3'-oxime | 448949 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | 6-bromoindirubin-3'-oxime | 448949 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | 6-bromoindirubin-3'-oxime | 448949 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | 6-bromoindirubin-3'-oxime | 448949 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | 6-bromoindirubin-3'-oxime | 448949 | drug-path |
| Chronic myeloid leukemia | R-HSA-9680350 | map05220 | 6-bromoindirubin-3'-oxime | 448949 | drug-path |
| Endometrial cancer | R-HSA-2077421 | map05213 | 16,16-dimethylprostaglandin E2 | 34040 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | 16,16-dimethylprostaglandin E2 | 34040 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | aconitine | 6172 | drug-path |
| Gap junction | R-HSA-190861 | map04540 | aconitine | 6172 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | epivincamine | 637570 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | epivincamine | 637570 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | epivincamine | 637570 | drug-path |
| Circadian rhythm - mammal | R-HSA-400253 | 0 | epivincamine | 637570 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | epivincamine | 637570 | drug-path |
| Amyotrophic lateral sclerosis (ALS) | Q8NDH6-2 | 0 | racecadotril | 107751 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | racecadotril | 107751 | drug-path |